Skip to content

Effectiveness of N-acetylcysteine on the Treatment of Achalasia

Effectiveness of N-acetylcysteine on the Treatment of Achalasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17012171
Enrollment
Unknown
Registered
2017-07-28
Start date
2017-07-26
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

achalasia

Interventions

Case series:take N-acetylcysteine for 2 weeks

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Eight achalasia patients, aged 18-65 years

Exclusion criteria

Exclusion criteria: Other diseases causing organic stricture, esophageal cancer, other digestive system malignancy, psychiatric neuropathy

Design outcomes

Primary

MeasureTime frame
Eckardt scores;

Secondary

MeasureTime frame
4-second integrated relaxation pressure;

Countries

China

Contacts

Public ContactLili Zhang

Tianjin Medical University General Hospital

lili724916@163.com+86 13821126302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026